ID

12796

Descripción

Rapamycin in Relapsed Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00874562

Link

https://clinicaltrials.gov/show/NCT00874562

Palabras clave

Versiones (1)
  1. 21/12/15 21/12/15 -
Subido en

21 de diciembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Lymphoblastic Leukemia NCT00874562

Inglés

Eligibility Acute Lymphoblastic Leukemia NCT00874562

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented acute lymphoblastic leukemia (l1 or l2 subtypes)
Descripción

all

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023449
first or subsequent relapse
Descripción

first or subsequent relapse

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0277556
365 days of age or older
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
greater than 7 days from any chemotherapy or immunotherapy, with the exception of intrathecal chemotherapy
Descripción

chemotherapy or immunotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0021083
absolute peripheral leukemia blast count of 1000 cells/ul or greater
Descripción

blast count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0427541
patient (or parent/guardian if patient is less than 18 years of age) must sign informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
burkitts leukemia (acute lymphoblastic leukemia l3 subtype)
Descripción

acute lymphoblastic leukemia l3 subtype

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279582
uncontrolled active infection
Descripción

active infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
pregnancy or mothers who are nursing
Descripción

pregnant or breastfeeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0549206
UMLS CUI [2]
C0006147
patient currently taking rapamycin
Descripción

rapamycin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0072980
UMLS CUI [2]
C2347852
patients with significant liver dysfunction as outlined in protocol
Descripción

liver dysfunction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0086565
severe concurrent disease, which in the judgment of the investigator, would make the patient inappropriate for entry into the study
Descripción

severe concurrent disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2]
C0439801
UMLS CUI [3]
C0009488
active psychiatric disease, substance abuse, or mental illness that would interfere with cooperation with the requirements of the trial
Descripción

active psychiatric disease, substance abuse, or mental illness

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0439801
UMLS CUI [3]
C0009488
Volver a la parte superior de la página

Similar models

Eligibility Acute Lymphoblastic Leukemia NCT00874562

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
all
Item
documented acute lymphoblastic leukemia (l1 or l2 subtypes)
boolean
C0023449 (UMLS CUI [1])
first or subsequent relapse
Item
first or subsequent relapse
boolean
C0277556 (UMLS CUI [1])
age
Item
365 days of age or older
boolean
C0001779 (UMLS CUI [1])
chemotherapy or immunotherapy
Item
greater than 7 days from any chemotherapy or immunotherapy, with the exception of intrathecal chemotherapy
boolean
C0392920 (UMLS CUI [1])
C0021083 (UMLS CUI [2])
blast count
Item
absolute peripheral leukemia blast count of 1000 cells/ul or greater
boolean
C0427541 (UMLS CUI [1])
informed consent
Item
patient (or parent/guardian if patient is less than 18 years of age) must sign informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
acute lymphoblastic leukemia l3 subtype
Item
burkitts leukemia (acute lymphoblastic leukemia l3 subtype)
boolean
C0279582 (UMLS CUI [1])
active infection
Item
uncontrolled active infection
boolean
C0009450 (UMLS CUI [1])
pregnant or breastfeeding
Item
pregnancy or mothers who are nursing
boolean
C0549206 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
rapamycin
Item
patient currently taking rapamycin
boolean
C0072980 (UMLS CUI [1])
C2347852 (UMLS CUI [2])
liver dysfunction
Item
patients with significant liver dysfunction as outlined in protocol
boolean
C0086565 (UMLS CUI [1])
severe concurrent disease
Item
severe concurrent disease, which in the judgment of the investigator, would make the patient inappropriate for entry into the study
boolean
C1321605 (UMLS CUI [1])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
active psychiatric disease, substance abuse, or mental illness
Item
active psychiatric disease, substance abuse, or mental illness that would interfere with cooperation with the requirements of the trial
boolean
C0021430 (UMLS CUI [1])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial